Anzeige
Mehr »
Sonntag, 31.08.2025 - Börsentäglich über 12.000 News
Wie SuperBuzz am Freitag parabolisch durchstartete - und warum das erst der Anfang sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D6F4 | ISIN: KYG6256B1068 | Ticker-Symbol: N/A
NASDAQ
07.03.25 | 21:46
12,020 US-Dollar
+5,16 % +0,590
1-Jahres-Chart
DENALI CAPITAL ACQUISITION CORP Chart 1 Jahr
5-Tage-Chart
DENALI CAPITAL ACQUISITION CORP 5-Tage-Chart

Aktuelle News zur DENALI CAPITAL ACQUISITION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.08.Denali Capital Acquisition Corp. - 8-K, Current Report1
DENALI CAPITAL ACQUISITION Aktie jetzt für 0€ handeln
21.08.Scilex CEO to resign as focus turns to Semnur - Denali merger11
21.08.Scilex subsidiary Semnur secures $20 million for pain drug development1
21.08.Scilex-Tochter Semnur sichert sich 20 Millionen US-Dollar für Schmerzmittelentwicklung2
21.08.Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (";Semnur"), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement ...2
15.08.Denali Capital Acquisition Corp. - 10-Q, Quarterly Report2
14.08.Denali Capital Acquisition Corp. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB2
13.08.Scilex stock jumps after SEC declares S-4 effective for Semnur merger17
13.08.Scilex subsidiary Semnur moves forward with Denali merger13
13.08.Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc.125Denali's registration statement on Form S-4 declared effective by the Securities and Exchange CommissionExtraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the...
► Artikel lesen
11.08.Denali Capital Acquisition Corp. - 8-K, Current Report2
08.08.Semnur Pharmaceuticals, Inc. - S-4/A, Registration of securities, business combinations2
08.08.Denali Capital Acquisition Corp. - S-4/A, Registration of securities, business combinations1
28.07.Denali Capital Acquisition passt Fusionsvertrag mit Semnur Pharmaceuticals an4
28.07.Denali Capital Acquisition Corp. - 8-K, Current Report2
23.07.Denali Capital Acquisition Corp. - S-4/A, Registration of securities, business combinations2
23.07.Semnur Pharmaceuticals, Inc. - S-4/A, Registration of securities, business combinations1
14.07.NSE - Denali Capital Acquisition Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities4
11.07.Denali Capital Acquisition Corp. - 8-K, Current Report2
02.07.Denali Capital Acquisition Corp. - S-4/A, Registration of securities, business combinations2
Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1